Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
Items 301–400 of 1,001
Neuropsychiatric Symptoms and Cholinergic Therapy for Alzheimer’s Disease
Levy, M. L., Cummings, J. L., & Kahn-Rose, R. (1999) · Gerontology · doi:10.1159/000052760 · Cited by 121
Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90140-4 · Cited by 125
Kordower, J. H., Gash, D. M., Bothwell, M. A., Hersh, L. B., & Mufson, E. J. (1989) · Neurobiology of Aging · doi:10.1016/s0197-4580(89)80013-2 · Cited by 118
Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease
Bohnen, N. I., Kaufer, D., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Davis, J. G., Constantine, G. M., Mathis, C. A., Moore, R. Y., & DeKosky, S. T. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.031 · Cited by 128
SHIMOHAMA, S., AKAIKE, A., & KIMURA, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34445.x · Cited by 118
Paul, S., Jeon, W. K., Bizon, J. L., & Han, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00043 · Cited by 127
The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
Cuello, A. C., Pentz, R., & Hall, H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00062 · Cited by 108
Huperzine A for Alzheimer's disease
Li, J., Wu, H. M., Zhou, R. L., Liu, G. J., & Dong, B. R. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005592.pub2 · Cited by 108
Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease
Teipel, S., Heinsen, H., Amaro, E., Grinberg, L. T., Krause, B., & Grothe, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.029 · Cited by 114
Selective Delayed Response Deficits in Parkinson's and Alzheimer's Disease
Freedman, M., & Oscar-Berman, M. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520090026011 · Cited by 113
Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease
Hall, A. M., Moore, R. Y., Lopez, O. L., Kuller, L., & Becker, J. T. (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.04.005 · Cited by 112
Aigner, T. G., Mitchell, S. J., Aggleton, J. P., DeLong, M. R., Struble, R. G., Price, D. L., Wenk, G. L., & Mishkin, M. (1987) · Psychopharmacology · doi:10.1007/bf00210833 · Cited by 113
Self-citationDementia and motor neuron disease: Morphometric, biochemical, and Golgi studies
Horoupian, D. S., Thal, L. J., Katzman, R., Terry, R. D., Davies, P., Hirano, A., DeTeresa, R. M., Fuld, P. A., Petito, C. K., Blass, J. P., et al. (1984) · Annals of Neurology · doi:10.1002/ana.410160306 · Cited by 116
Reevaluation of the contribution of the basal forebrain cholinergic system to memory
Kesner, R. P. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80122-2 · Cited by 113
Effects of rosmarinic acid on nervous system disorders: an updated review
Rahbardar, M. G., & Hosseinzadeh, H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01935-w · Cited by 115
Lee, B., Jung, K., & Kim, D. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.021 · Cited by 112
Rodr�guez-Puertas, R., Pascual, J., Vilar�, T., & Pazos, �. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199708)26:4<341::aid-syn2>3.0.co;2-6 · Cited by 112
Rösler, M., Retz, W., Retz-Junginger, P., & Dennler, H. J. (1999) · Behavioural Neurology · doi:10.1155/1999/168023 · Cited by 109
The Fall of Sleep K-Complex in Alzheimer Disease
De Gennaro, L., Gorgoni, M., Reda, F., Lauri, G., Truglia, I., Cordone, S., Scarpelli, S., Mangiaruga, A., D’atri, A., Lacidogna, G., et al. (2017) · Scientific Reports · doi:10.1038/srep39688 · Cited by 111
Corey‐Bloom, J. (2002) · International Psychogeriatrics · doi:10.1017/s1041610203008664 · Cited by 120
Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels
Isaacson, L. G., Saffran, B. N., & Crutcher, K. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90062-5 · Cited by 111
Astroglia in Alzheimer's disease
Frederickson, R. C. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90036-w · Cited by 120
Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects
Grothe, M. J., Ewers, M., Krause, B., Heinsen, H., & Teipel, S. J. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.09.011 · Cited by 104
Camps, P., Cusack, B. M., Mallender, W. D., Achab, R. E., Morral, J., Muñoz‐Torrero, D., & Rosenberry, T. L. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23214-4 · Cited by 109
Karakaya, T., Fußer, F., Schroder, J., & Pantel, J. (2013) · Current Neuropharmacology · doi:10.2174/157015913804999487 · Cited by 102
Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation
Halliday, G. M., McCann, H., Pamphlett, R., Brooks, W. S., Creasey, H. M., McCusker, E. A., Cotton, R. G. H., Broe, G. A., & Harper, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227741 · Cited by 120
López‐Ortiz, S., Pinto-Fraga, J., Valenzuela, P. L., Martín-Hernández, J., Seisdedos, M. M., García, Ó., Toschi, N., Giuliano, F. D., Garaci, F. G., Mercuri, N. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062897 · Cited by 115
Tuszynski, M. H., & Blesch, A. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46028-7 · Cited by 117
Region- and peptide-specific regulation of the neurotrophins by estrogen
Jezierski, M., & Sohrabji, F. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00244-8 · Cited by 116
Hertz, L. (1989) · Brain Research Reviews · doi:10.1016/0165-0173(89)90017-9 · Cited by 113
Nazarali, A. J., & Reynolds, G. P. (1992) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711237 · Cited by 111
Rasool, C. G., Svendsen, C. N., & Selkoe, D. J. (1986) · Annals of Neurology · doi:10.1002/ana.410200407 · Cited by 104
Basal Forebrain Cholinergic Neurons and Alzheimer’s Disease
Höhmann, C. F., Antuono, P., & Coyle, J. T. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8_2 · Cited by 109
Self-citationRedox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
Response of septal cholinergic neurons to axotomy
Armstrong, D. M., Terry, R. D., DeTeresa, R. M., Bruce, G., Hersh, L. B., & Gage, F. H. (1987) · The Journal of Comparative Neurology · doi:10.1002/cne.902640309 · Cited by 105
A Clinical Overview of Cholinesterase Inhibitors in Alzheimer’s Disease
Martin, F. (2002) · International Psychogeriatrics · doi:10.1017/s1041610203008688 · Cited by 100
Hanyu, H., Asano, T., Sakurai, H., Tanaka, Y., Takasaki, M., & Abe, K. (2002) · PubMed · Cited by 114
Nongeniculate afferents to striate cortex in macaques
Doty, R. W. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902180204 · Cited by 104
Nicotinic receptor–mediated protection against β-amyloid neurotoxicity
Shimohama, S., & Kihara, T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01100-8 · Cited by 112
A structural basis for memory storage in mammals
Woolf, N. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00094-4 · Cited by 121
Gaykema, R. P., & Zaborszky, L. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961028)374:4<555::aid-cne6>3.0.co;2-0 · Cited by 106
German, D. C., Bruce, G., & Hersh, L. B. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90391-x · Cited by 103
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance
Geula, C., Dunlop, S. R., Ayala, I., Kawles, A. S., Flanagan, M. E., Gefen, T., & Mesulam, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15471 · Cited by 102
“Molecular characteristics of BFCN may also contribute to their vulnerability in AD and DLBD.”
BackgroundResultInfluentialCholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse
Perez, S. E., Dar, S., Ikonomović, M. D., DeKosky, S. T., & Mufson, E. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.015 · Cited by 106
Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease
Rinne, J. O., Paljärvi, L., & Rinne, U. K. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90260-7 · Cited by 102
Buccafusco, J. J., Jackson, W. J., Terry, A. V., Marsh, K. C., Decker, M. W., & Arnerić, S. P. (1995) · Psychopharmacology · doi:10.1007/bf02311172 · Cited by 102
Chapter II Neurobiology and neuropathology of the human hypothalamus
Swaab, D. F. (1997) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(97)80004-8 · Cited by 113
Arendt, T., Brückner, M. K., Bigl, V., & Marcova, L. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903510203 · Cited by 99
3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice
Gail Canter, R., Huang, W.-C., Choi, H., Wang, J., Ashley Watson, L., Yao, C. G., Abdurrob, F., Bousleiman, S. M., Young, J. Z., Bennett, D. A., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0599-8 · Cited by 89
Antipsychotic Medications and the Elderly: Effects on Cognition and Implications for Use
Byerly, M., Weber, M., Brooks, D. L., Snow, L. R., Worley, M. A., & Lescouflair, E. (2001) · Drugs & Aging · doi:10.2165/00002512-200118010-00004 · Cited by 108
Dawbarn, D., Allen, S. J., & Semenenko, F. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90284-4 · Cited by 101
Dopamine beta‐hydroxylase and its genetic variants in human health and disease
Gonzalez‐Lopez, E., & Vrana, K. E. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14893 · Cited by 102
Giovannini, M. G., Scali, C., Prosperi, C., Bellucci, A., Pepeu, G., & Casamenti, F. (2003) · PubMed · Cited by 105
Rivastigmine reverses aluminum-induced behavioral changes in rats
Abdel‐Aal, R. A., Assi, A.-A. A., & Kostandy, B. B. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.011 · Cited by 109
Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
Mufson, E., Counts, S., Fahnestock, M., & Ginsberg, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788855 · Cited by 104
Neurotransmitter and Receptor Deficits in Senile Dementia of the Alzheimer Type
Quirion, R., Martel, J.-C., Robitaille, Y., Etienne, P. E., Wood, P. L., Nair, N. P. V., & Gauthier, S. G. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037215 · Cited by 107
Schaeffer, E. L., & Gattaz, W. F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1092-0 · Cited by 114
Salehi, A., Lucassen, P. J., Pool, C. W., Gonatas, N. K., Ravid, R., & Swaab, D. F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90291-7 · Cited by 97
Relational Integration and Executive Function in Alzheimer's Disease.
Waltz, J. A., Knowlton, B. J., Holyoak, K. J., Boone, K. B., Back-Madruga, C., McPherson, S., Masterman, D., Chow, T., Cummings, J. L., & Miller, B. L. (2004) · Neuropsychology · doi:10.1037/0894-4105.18.2.296 · Cited by 93
Pharmacokinetics and Pharmacodynamics of Scopolamine after Subcutaneous Administration
Ebert, U., Siepmann, M., Oertel, R., Wesnes, K. A., & Kirch, W. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04812.x · Cited by 97
Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease
de la Monte, S. M., Wells, S. E., Hedley‐Whyte, E. T., & Growdon, J. H. (1989) · Annals of Neurology · doi:10.1002/ana.410260302 · Cited by 100
The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease
Woolf, N. J., Jacobs, R. W., & Butcher, L. L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90391-1 · Cited by 97
Deng, H., & Mi, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1950-9 · Cited by 101
Mufson, E. J., Cai, W. J., Jaffar, S., Chen, E., Stebbins, G. T., Sendera, T. J., & Kordower, J. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01960-5 · Cited by 100
Midlatency auditory evoked responses: differential abnormality of P1 in Alzheimer's disease
Buchwald, J. S., Erwin, R. J., Read, S., Lancker, D. V., & Cummings, J. L. (1989) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/0168-5597(89)90005-1 · Cited by 96
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed
Flicker, C., Serby, M., & Ferris, S. H. (1990) · Psychopharmacology · doi:10.1007/bf02244414 · Cited by 95
“Flicker cholinergic neurons (Whitehouse et al. 1981), of decreases in particular subtypes of muscarinic receptors (Mash et al.”
Classics in Chemical Neuroscience: Donepezil
Brewster, J. T., Dell’Acqua, S., Thach, D. Q., & Sessler, J. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00517 · Cited by 98
Nardone, R., Bergmann, J., Kronbichler, M., Kunz, A. B., Klein, S., Caleri, F., Tezzon, F., Ladurner, G., & Golaszewski, S. M. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0129-1 · Cited by 101
Martin, L., Blackstone, C., Levey, A., Huganir, R., & Price, D. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-05-02249.1993 · Cited by 95
Self-citationBlurton-Jones, M. M., Roberts, J. A., & Tuszynski, M. H. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990322)405:4<529::aid-cne6>3.0.co;2-y · Cited by 95
Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
Imbimbo, B. P., Ottonello, S., Frisardi, V., Solfrizzi, V., Greco, A., Seripa, D., Pilotto, A., & Panza, F. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.93 · Cited by 90
Age-related cerebral atrophy in nonhuman primates predicts cognitive impairments
Picq, J., Aujard, F., Volk, A., & Dhénain, M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.009 · Cited by 96
Aharon-Peretz, J., Harel, T., Revach, M., & Ben-Haim, S. A. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530330041013 · Cited by 92
Contingent Vulnerability of Entorhinal Parvalbumin-Containing Neurons in Alzheimer’s Disease
Solodkin, A., Veldhuizen, S. D., & Van Hoesen, G. W. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03311.1996 · Cited by 92
Rate of forgetting in mild Alzheimer's-type dementia
Hart, R. P., Kwentus, J. A., Harkins, S. W., & Taylor, J. R. (1988) · Brain and Cognition · doi:10.1016/0278-2626(88)90019-x · Cited by 99
Spatial learning deficits in the aged rat: neuroanatomical and neurochemical correlates
Lee, J. M., Ross, E. R. S., Gower, A., Paris, J. M., Mårtensson, R., & Lorens, S. A. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90073-6 · Cited by 101
Stam, K. J., Tavy, D. L. J., Jelles, B., Achtereekte, H. A. M., Slaets, J. P. J., & Keunen, R. W. M. (1994) · Brain Topography · doi:10.1007/bf01186772 · Cited by 94
Alzheimer's Disease and Down's Syndrome*
Price, D. L., Whitehouse, P. J., Struble, R. G., Coyle, J. T., Clark, A. W., DeLong, M. R., Cork, L. C., & Hedreen, J. C. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb26850.x · Cited by 102
Self-citationKesner, R. P., Crutcher, K. A., & Measom, M. O. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90009-6 · Cited by 97
Sayer, R., Law, E., Connelly, P., & Breen, K. C. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.10.007 · Cited by 98
Pirttilä, T., Wilcock, G., Truyen, L., & Damaraju, C. V. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00885.x · Cited by 92
Attenuation of scopolamine-induced amnesia in mice
Stone, W., Croul, C., & Gold, P. E. (1988) · Psychopharmacology · doi:10.1007/bf00216073 · Cited by 93
Phenolic acids from malt are efficient acetylcholinesterase and butyrylcholinesterase inhibitors
Szwajgier, D., & Borowiec, K. (2012) · Journal of the Institute of Brewing · doi:10.1002/jib.5 · Cited by 96
Cerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin
Raskind, M. A. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040092013 · Cited by 91
Advances in the pharmacotherapy of Alzheimer's disease.
Gauthier, S. G. (2002) · Europe PMC (PubMed Central) · Cited by 113
Mandel, R. J., Gage, F. H., & Thal, L. J. (1989) · Behavioural Brain Research · doi:10.1016/0166-4328(89)90004-1 · Cited by 97
MINOSHIMA, S., CROSS, D. J., FOSTER, N. L., HENRY, T. R., & KUHL, D. E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07852.x · Cited by 90
Neuron loss in the nucleus basalis of meynert in parkinsonism‐dementia complex of Guam
Nakano, I., & Hirano, A. (1983) · Annals of Neurology · doi:10.1002/ana.410130118 · Cited by 91
Hömberg, V., Hefter, H., Granseyer, G., Strauß, W. H., Lange, H., & Hennerici, M. G. (1986) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(86)90143-4 · Cited by 96
Cheng, Y., Lin, C., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052283 · Cited by 93
Thenmozhi, A. J., Dhivyabharathi, M., Raja, T. R. W., Manivasagam, T., & Essa, M. M. (2015) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000016 · Cited by 103
Armstrong, D. M. (1986) · Journal of Comparative Neurology · doi:10.1002/cne.902500108 · Cited by 91
Chetty, C. A., Bhardwaj, H., Kumar, G. P., Devanand, T., Sekhar, C. S. A., Aktürk, T., Kıyı, İ., Yener, G., Güntekin, B., Joseph, J., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01582-w · Cited by 97
Bishop, K. M., Hofer, E. K., Mehta, A., Ramirez, A., Sun, L., Tuszynski, M. H., & Bartus, R. T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.004 · Cited by 95
Tanaka, K.-I., Ogawa, N., Asanuma, M., Kondo, Y., & Nomura, M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00400-3 · Cited by 95
Nerve Growth Factor and Alzheimer's Disease
Scott, S. A., & Crutcher, K. A. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.3.179 · Cited by 96
Zhang, F., Xu, S., & Iadecola, C. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00302-y · Cited by 93
Pennisi, G., Ferri, R., Lanza, G., Cantone, M., Pennisi, M., Puglisi, V., Malaguarnera, G., & Bella, R. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0554-9 · Cited by 89
Clinical Physiology of Taste and Smell
Schiffman, S. S., & Gatlin, C. A. (1993) · Annual Review of Nutrition · doi:10.1146/annurev.nu.13.070193.002201 · Cited by 95
Dementia and Parkinson's Disease
Gibb, W. R. G. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.596 · Cited by 91
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.